Skip to main content
logo
Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
9.23
-0.18 (-1.91%)
Aug 20, 2026, 4:00 PM EDT - Market closed

Xilio Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-21.83-35.04-58.24-76.4-88.22-75.8
Depreciation & Amortization
1.341.541.641.91.851.5
Loss (Gain) From Sale of Assets
--0000.02
Stock-Based Compensation
7.866.946.437.388.424.96
Other Operating Activities
-5.26-3.56-0.160.220.38
Change in Accounts Receivable
-6-5----
Change in Accounts Payable
-1.790.151.53-2.060.49-2.82
Change in Unearned Revenue
-35.5927.8832.78---
Change in Other Net Operating Assets
0.672.1-2.520.411.52-8.99
Operating Cash Flow
-60.6-4.99-18.38-68.62-75.72-80.75
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.67-0.52-0.04-0.49-1.87-1.1
Investing Cash Flow
-0.67-0.52-0.04-0.49-1.87-1.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----0.98
Long-Term Debt Repaid
---3.38-6.75-0.09-1.09
Net Debt Issued (Repaid)
---3.38-6.75-0.09-0.11
Issuance of Common Stock
77.3387.7832.580.20.02116.64
Other Financing Activities
-1.55-----0.75
Financing Cash Flow
75.7887.7829.2-6.55-0.07260.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
14.5182.2710.78-75.66-77.66178.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-61.27-5.51-18.41-69.11-77.59-81.85
Free Cash Flow Growth
------
Free Cash Flow Margin
-95.59%-12.59%-290.26%---
Free Cash Flow Per Share
-9.31-1.22-4.82-35.19-39.66-204.40
Levered Free Cash Flow
-37.568.03-16.23-42.32-45.9-52.31
Unlevered Free Cash Flow
-37.568.03-16.23-41.88-45.4-51.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0.060.570.560.49
Change in Working Capital
-42.7125.1331.78-1.662-11.8
SEC Filings: 10-K · 10-Q